Intellia Therapeutics (NTLA) Insider Trading & Ownership $20.54 +0.58 (+2.91%) Closing price 04:00 PM EasternExtended Trading$20.78 +0.23 (+1.14%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.00MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$541.70K Get NTLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NTLA Insider Buying and Selling by Quarter Intellia Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/1/2025Birgit C SchultesEVPSell31$17.38$538.78 10/1/2025Michael P DubeCAOSell1,871$17.38$32,517.98 8/20/2025William J ChaseDirectorBuy100,000$10.03$1,003,000.00 7/23/2025Edward J Dulac IIIEVPSell7,462$14.02$104,617.24 7/2/2025Michael P DubeCAOSell2,503$9.95$24,904.85 7/1/2025Eliana ClarkEVPSell1,022$9.82$10,036.04 7/1/2025Jesse GoodmanDirectorSell1,547$9.23$14,278.81 4/29/2025Muna BhanjiDirectorSell265$8.50$2,252.50 1/29/2025Muna BhanjiDirectorSell265$9.97$2,642.05 1/3/2025John M LeonardCEOSell26,807$12.18$326,509.26 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/3/2025Michael P DubeCAOSell1,372$12.18$16,710.96 1/2/2025Eliana ClarkEVPSell556$12.03$6,688.68 (Data available from 1/1/2013 forward) NTLA Insider Trading Activity - Frequently Asked Questions Who is on Intellia Therapeutics' Insider Roster? The list of insiders at Intellia Therapeutics includes Birgit C Schultes, David Lebwohl, Edward J Dulac III, Eliana Clark, Glenn Goddard, James Basta, Jesse Goodman, John M Leonard, Laura Sepp-Lorenzino, Michael P Dube, Muna Bhanji, and William J Chase. Learn more on insiders at NTLA. What percentage of Intellia Therapeutics stock is owned by insiders? 3.10% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings. Which Intellia Therapeutics insiders have been buying company stock? The following insider purchased NTLA shares in the last 24 months: William J Chase ($1,003,000.00). How much insider buying is happening at Intellia Therapeutics? Insiders have purchased a total of 100,000 NTLA shares in the last 24 months for a total of $1,003,000.00 bought. Which Intellia Therapeutics insiders have been selling company stock? The following insiders have sold NTLA shares in the last 24 months: Birgit C Schultes ($538.78), David Lebwohl ($172,134.78), Edward J Dulac III ($104,617.24), Eliana Clark ($26,011.37), Glenn Goddard ($158,052.90), James Basta ($75,778.03), Jesse Goodman ($14,278.81), John M Leonard ($892,818.84), Laura Sepp-Lorenzino ($65,679.25), Michael P Dube ($112,381.91), and Muna Bhanji ($11,228.05). How much insider selling is happening at Intellia Therapeutics? Insiders have sold a total of 81,386 Intellia Therapeutics shares in the last 24 months for a total of $1,633,519.96 sold. Intellia Therapeutics Key ExecutivesDr. John M. Leonard M.D. (Age 67)President, CEO & Director Compensation: $1.06MMr. Glenn G. Goddard CPA (Age 53)Executive VP, CFO & Treasurer Compensation: $630.91kDr. Laura Sepp-Lorenzino Ph.D. (Age 63)Executive VP & Chief Scientific Officer Compensation: $670.58kMr. James E. Basta Esq. (Age 58)J.D., Executive VP, General Counsel & Corporate Secretary Compensation: $616.15kDr. David Lebwohl M.D. (Age 69)Executive VP & Chief Medical Officer Compensation: $671.42kMr. Derek Hicks (Age 50)Executive VP & Chief Business Officer Compensation: $823.42kMr. Nessan Bermingham Ph.D. (Age 51)Founder & Member of Scientific Advisor Board Compensation: $1.38MDr. Rachel E. Haurwitz Ph.D. (Age 38)Co-Founder Dr. Andrew May Ph.D.Founder and Member of Scientific Advisor BoardDr. Jennifer A. Doudna Ph.D. (Age 60)Founder & Member of Scientific Advisor Board More Insider Trading Tools from MarketBeat Related Companies Beam Therapeutics Insider Selling CRISPR Therapeutics Insider Selling Editas Medicine Insider Selling Twist Bioscience Insider Selling Merus Insider Selling Grifols Insider Selling Rhythm Pharmaceuticals Insider Selling Cytokinetics Insider Selling Avidity Biosciences Insider Selling Nuvalent Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges This page (NASDAQ:NTLA) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
